-
520764-1GPalladium(II) acetate is a homogenous oxidation catalyst. It participates in the activation of alkenic and aromatic compounds towards oxidative inter- and intramolecular nucleophilic reactions.
-
520764-25GPalladium(II) acetate is a homogenous oxidation catalyst. It participates in the activation of alkenic and aromatic compounds towards oxidative inter- and intramolecular nucleophilic reactions.
-
520764-5GPalladium(II) acetate is a homogenous oxidation catalyst. It participates in the activation of alkenic and aromatic compounds towards oxidative inter- and intramolecular nucleophilic reactions.
-
683124-500MGApplication Application Guide for Palladium Catalyzed Cross-Coupling Reactions Application Guide for Palladium Catalyzed Cross-Coupling Reactions Legal Information Product of Umicore Additional information available at www.pmc.
-
683124-5GApplication Application Guide for Palladium Catalyzed Cross-Coupling Reactions Application Guide for Palladium Catalyzed Cross-Coupling Reactions Legal Information Product of Umicore Additional information available at www.pmc.
-
88022401-1VL
Sigma-Aldrich
PC-12 CELLS RAT ADRENAL PHAEOCHROMOCYTOMA (C15-1311-226)
Price: $936.00List Price: $1,040.00Cell Line Origin Rat adrenal phaeochromocytoma Cell Line Description Derived from a transplantable rat adrenal phaeochromocytoma. Respond reversibly to nerve growth factor by induction of neuronal phenotype. -
-
1526007-250MGThis product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the
-
B019-250MGBiochem/physiol Actions Calmodulin antagonist α-adrenoceptor antagonist. Features and Benefits This compound is a featured product for ADME Tox research.
-
BP1072This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the
-
BP520This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the
-
1530004-200MGThis product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the